[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Redeye_ Avatar @Redeye_ Redeye

Redeye posts on X about $mob, $geno, strong, $binv the most. They currently have XXXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence cryptocurrencies XXXXX% finance XXXX%

Social topic influence $mob 11.11%, $geno #1, strong 11.11%, $binv 7.41%, capital markets 7.41%, $lime 3.7%, $indt 3.7%, $lifco 3.7%, $bonex 3.7%, fda XXX%

Top accounts mentioned or mentioned by @cryptoreview24 @aiagentmaya

Top assets mentioned MobileCoin (MOB) iMe Lab (LIME) Bware (INFRA)

Top Social Posts

Top posts by engagements in the last XX hours

"Redeye updates its Base Case and forecasts for Lime following the Q3 report. $LIME"
X Link 2025-10-21T13:26Z 14.5K followers, XXX engagements

"Redeye updates its estimates and valuation after Indutrades Q3 2025 report. $INDT"
X Link 2025-10-21T13:25Z 14.5K followers, XXX engagements

"Redeye comments on Moberg Pharmas Q3 report in which sales came in slightly ahead of our forecast at SEK4.0m. $MOB"
X Link 2025-11-11T08:20Z 14.5K followers, XXX engagements

"Redeye views the Q3 report as solid with sales slightly ahead of expectations and tighter cost control than anticipated. $MOB"
X Link 2025-11-14T07:37Z 14.5K followers, XXX engagements

"Redeye updates its estimates and valuation after Lifcos Q3 2025 report. $LIFCO"
X Link 2025-10-27T08:47Z 14.5K followers, XXX engagements

"Redeye comments on BONESUPPORT announcing that the pathway for CERAMENT V would be transferred from a 510k to a De Novo process following discussions with the FDA. $BONEX"
X Link 2025-12-02T12:14Z 14.5K followers, 1875 engagements

"Redeye comments on Guard Therapeutics announcing its evaluation of the complete results from the phase IIb POINTER study. $GUARD"
X Link 2025-12-05T07:52Z 14.5K followers, XXX engagements

"Redeye notes that InfraComs Q3 2025 report aligned with net sales estimates but EBITDA was weighed on by higher-than-anticipated operating expenses (OPEX). $INFRA"
X Link 2025-11-11T08:19Z 14.5K followers, XXX engagements

"Redeye views Genovis' soft Q3 as a bump on the road ahead of a strong Q4. $GENO"
X Link 2025-11-12T07:35Z 14.4K followers, 1207 engagements

"Redeye initiates coverage of Ferroamp a greentech company offering a modular hardware and software platform for smart energy control in buildings. $FERRO"
X Link 2025-11-26T07:14Z 14.4K followers, XXX engagements

"Redeye initiates coverage of AAC Clyde Space a leading smallsat provider with a strong position within satellite components and missions now growing into the Data & Services business. $AAC"
X Link 2025-12-05T07:51Z 14.5K followers, XXX engagements

"Redeye is increasingly optimistic about Bioinvent's BI-1808. In the latest readout presented at ASH X out of XX patients with CTCL presented a response. $BINV"
X Link 2025-12-08T10:35Z 14.5K followers, XXX engagements

"Redeye comments on Bioinvent after publishing strong data with BI-1808 yesterday the company returns with a positive readout with the BI-1206 triplet in NHL. $BINV"
X Link 2025-12-08T14:21Z 14.5K followers, XXX engagements

"Redeye comments on Genovis decision to acquire the remaining XX% of SEQURNA viewing it as a logical synergistic move that leverages its growing net cash and adds exposure to the sizable and growing genomics market. $GENO"
X Link 2025-07-02T09:46Z 14.5K followers, 1485 engagements

"Redeye has interviewed SSH Communications Security's CEO Rami Raulas who shares the key takeaways from the capital markets day and how the partnership with Leonardo is progressing. $SSH1V"
X Link 2025-10-27T13:44Z 14.5K followers, XXX engagements

"Redeye comments on the announcement that Moberg Pharma has signed an exclusive license agreement with Karo Healthcare for the commercialisation of MOB-015/Terclara in XX European markets. $MOB"
X Link 2025-11-05T10:08Z 14.5K followers, 1214 engagements

"Redeye views Genovis Q3 as softer than anticipated. $GENO"
X Link 2025-11-07T08:26Z 14.5K followers, 1056 engagements

"Redeye leaves a comment following Cinclus announcement that its lead candidate linaprazan glurate has been included on Chinas 2025 National Reimbursement Drug List. $CINPHA"
X Link 2025-12-08T10:37Z 14.5K followers, XXX engagements

"Redeye updates its estimates and valuation after Surgical Sciences capital markets day. $SUS"
X Link 2025-12-09T07:25Z 14.5K followers, XXX engagements